Search results for

Our last monthly roundup of the year includes new music from Theo Parrish, Kim Ann Foxman, Romare, Helena Hauff, Afrikan Sciences, and Frank & Tony.

Clinton never moved back to Park Ridge, Ill., but when she talks about the America she wants to build, you can hear hints of what that suburb was like in the 1950s.

Organizers of a campaign to save the Willow Run Bomber Plant in Ypsilanti Township, Mich., say they've raised enough money to buy a part of the facility and turn it into a museum.

Patty Stonesifer once held a top spot at Microsoft. After that, she spent years at the helm of philanthropy giant the Gates Foundation. But this year, Stonesifer downsized. She's taken on a smaller-scale role as CEO of Martha's Table, a Washington, D.C., nonprofit that serves the poor.

NPR Music remembers musicians — singers, songwriters, instrumentalists — and other visionaries we lost in 2016. Explore and celebrate their musical legacies.

Host Michel Martin pays tribute to former Congressman William Gray, who died Monday. He served as the first black majority whip in the House of Representatives and pushed Congress to stop American investment in South Africa during apartheid. He went on to serve as the long-time leader of the United Negro College Fund.

Ingraham tweeted that Parkland shooting survivor and gun-control activist David Hogg whined about being rejected from four colleges. She apologized after Hogg called for an ad boycott of her show.

The Hunting Ground, shortlisted for next year's Oscars, has inspired a backlash — not only for its perspective but for the factual foundation on which it is based and its reporting methods.

Bestselling author Maeve Binchy wrote stories about fictional Chestnut Street all her life. When she died in 2012, they were collected into a volume reviewer Bobbi Dumas calls lyrical and accessible.

"It would be so much more convenient if the earthquake would send us an email in advance with all the details of its arrival," a fearful Lucas told his mother, a journalist.

Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives by doing so. But nearly a third of the medicines aren't new or were repurposed many times for financial gain.

California is seen as an Obamacare success story. But tens of thousands of people in the northern part of the state have only one insurer available on the health plan exchange.